Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Intuitive Surgical (ISRG) A Buy Ahead of Q2 Earnings Announcement?
Medical instrument provider Intuitive Surgical (ISRG - Free Report) is set to report second-quarter earnings results on Thursday after the bell. The maker of the popular da Vinci Surgical System, Intuitive Surgical is a Zacks Rank #2 (Buy) stock. The established health care company has missed the earnings mark in two of the last four quarters. But with sales and earnings estimates projecting significant year-over-year increases, is ISRG a buy?
Intuitive Surgical is expected to post a profit of $1.32/share, which would reflect solid growth of 15.79% versus the same quarter last year. Estimates for the quarter have remained steady over the past 60 days. Revenues are projected to rise 13.82% to $1.73 billion.
ISRG stock has surged nearly 34% this year. The health care giant is currently showing a negative Zacks Earnings ESP (Expected Surprise Prediction) of -1.29%. As such, our proprietary Zacks Model does not conclusively predict an earnings beat for the upcoming announcement.